Literature DB >> 7878630

Pulmonary embolism in patients with upper extremity DVT associated to venous central lines--a prospective study.

M Monreal1, A Raventos, R Lerma, J Ruiz, E Lafoz, A Alastrue, J F Llamazares.   

Abstract

We performed a prospective study in 86 consecutive patients with central vein catheter-related deep venous thrombosis (DVT) of the upper extremity, to evaluate the prevalence of pulmonary embolism (PE), and to identify clinical variables that would increase the likelihood of developing PE in an individual patient. Since upper-extremity DVT was established, all patients received intravenous heparin therapy. Then, a ventilation-perfusion lung scan was obtained within 24 h of DVT diagnosis, whether respiratory symptoms were present or not. Six points of clinical information were recorded on entering in the study, and then compared with the scintigraphic findings: age, sex, the underlying disease, the catheter material, the character of the infusate, and the duration of cannulation. Thirteen patients were considered to have PE. Sixty-six patients were finally classified as having a normal lung scan, and 7 patients were excluded from the study (because of indeterminate lung scan 6; because of femoropopliteal thrombosis simultaneously present 1). Two out of the 13 patients with PE subsequently died because of recurrent, massive embolism, despite adequate heparin therapy. PE was more commonly present in patients with polyvinyle chloride or polyethylene catheters (10/38, 26%) as compared to patients with either polyurethane or siliconized catheters (3/41, 7%; p < 0.05, Chi-Square test; Odds Ratio = 4.52, 95% CI 1.01-23.07). We conclude that PE is not a rare event in these patients, and it may be life-threatening even despite adequate heparin therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7878630

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  20 in total

Review 1.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

2.  Upper extremity deep venous thromboembolism following arthroscopic labral repair of the shoulder and biceps tenodesis: a case report.

Authors:  Thomas J S Durant; Brian T Swanson; Mark P Cote; Donald A Allen; Robert A Arciero; Augustus D Mazzocca
Journal:  Int J Sports Phys Ther       Date:  2014-05

3.  Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports.

Authors:  Jo Caers; Christel Fontaine; Vincent Vinh-Hung; Johan De Mey; Gerrit Ponnet; Chris Oost; Jan Lamote; Jacques De Greve; Benjamin Van Camp; Patrick Lacor
Journal:  Support Care Cancer       Date:  2004-11-05       Impact factor: 3.603

4.  Venous Thrombosis of the Upper Extremities.

Authors:  Agnes Y. Y. Lee; Jeffrey S. Ginsberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06

Review 5.  Management of occlusion and thrombosis associated with long-term indwelling central venous catheters.

Authors:  Jacquelyn L Baskin; Ching-Hon Pui; Ulrike Reiss; Judith A Wilimas; Monika L Metzger; Raul C Ribeiro; Scott C Howard
Journal:  Lancet       Date:  2009-07-11       Impact factor: 79.321

6.  Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab.

Authors:  Mitsukuni Suenaga; Nobuyuki Mizunuma; Kokoro Kobayashi; Eiji Shinozaki; Satoshi Matsusaka; Keisho Chin; Yasutoshi Kuboki; Takashi Ichimura; Masato Ozaka; Mariko Ogura; Yoshimasa Fujiwara; Kiyoshi Matsueda; Fumio Konishi; Kiyohiko Hatake
Journal:  Med Oncol       Date:  2009-08-21       Impact factor: 3.064

7.  Prophylaxis of port system-associated thromboses in advanced oncology patients using heparin flushing.

Authors:  C Lersch; W Kotowa; S Fung; D Janssen
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-04       Impact factor: 4.553

8.  Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.

Authors:  J Deerojanawong; S M Sawyer; A M Fink; K B Stokes; C F Robertson
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

9.  Large Cohort Study of Central Venous Catheter Thrombosis during Intravenous Antibiotic Therapy.

Authors:  Stéphanie Guillet; Valérie Zeller; Vincent Dubée; Françoise Ducroquet; Nicole Desplaces; Marie Hélène Horellou; Simon Marmor; Jean Marc Ziza
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

10.  Systemic thrombolysis in the upper extremity deep vein thrombosis.

Authors:  Roxana Sadeghi; Morteza Safi
Journal:  ARYA Atheroscler       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.